• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

The Weekly Roundup: May 29-June 2


ICYMI, this week we had stories about dermatologic disparities among veterans and LGBTQIA+ patients, pediatric melanoma, a European approval for hidradenitis suppurativa, and more.

Dermatologic Concerns Among Veterans and Members of the Military

This Memorial Day, the Dermatology Times® team is taking the time to spotlight dermatologic disparities and concerns among veterans and active members of the military.

Consent and Experience

In this month’s Legal Eagle column, we delve into cases involving informed consent.

Discovering Dermatology Times: May 2023

Learn more about the in-depth topics covered in the May 2023 issue of Dermatology Times®.

POLL: Do You Feel Comfortable Prescribing Adalimumab Biosimilars?

Click here to answer this week's poll.

The Mainstream Patient: May 30

This week's edition of the Mainstream Patient features stories about 8 Black-owned holistic beauty brands, tear trough filler for under-eye bags, dermatologist-approved SPF-containing moisturizers, and more.

Cold Anesthesia Well-Tolerated, Reduced Pain in Injections for Nodulocystic Acne

Cryoanesthesia was safe and reduced pain in patients receiving intralesional triamcinolone steroid injections.

Biological Patterns in Pediatric Melanoma

Researchers conducted a systematic review of pediatric melanoma.

Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.

Michael Cameron, MD, FAAD, Shares Challenges, Insights Into Opening a New Practice

Cameron Dermatology, which just opened in NYC, will address both medical and cosmetic issues.

Pointers With Portela: Products to Build a Skin Care Routine

In this week’s Pointers with Portela, the 208SkinDoc explains his recommendations for effective products to buy to start a skin care routine.

What's Trending in Skin Care: May 2023

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of May.

Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial

The phase 3b trial showed improvements to minimal disease activity in adults with the condition.

For Patients With Birthmarks, Psychosocial Interventions Improved Wellbeing

A public exhibition spotlighting individuals with birthmarks improved participants’ wellbeing and sense of self image.

Previewing Fall Clinical PA & NP Conference With James Del Rosso, DO

As senior director, Del Rosso is looking forward to presenting numerous sessions and welcoming attendees to Orlando.

Amgen to Present New MOSAIC Phase 4 Data at EULAR 2023

Apremilast is being examined for the treatment of psoriatic arthritis.

Addressing Disparities and Ensuring Equitable Care for LGBTQIA+ Patients

As Pride Month begins, the Dermatology Times® team wants to uplift LGBTQIA+ clinicians, patients, and topics in dermatology.

European Commission Approves Secukinumab for Hidradenitis Suppurativa

The approval makes the drug Europe’s first and only IL-17A inhibitor approved for the condition.

Scientists Identify Treatment Option for Rare Pansclerotic Morphea

Scientists have found a new therapy for the severe inflammatory skin disorder.

WHO Calls For Caution When it Comes to Using AI For Health

The World Health Organization shared its enthusiasm for the “appropriate” use of these technologies. However, they are calling for caution to be exercised to protect and promote human well-being, safety, and autonomy and preserve public health.

New Study Uncovers Cells and Pathways Driving Psoriasis Inflammation and Severity

Researchers examined the disease while going beyond current diagnostic tools.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.